Trupanion grows Q1 revenue as Lemonade pet tops $500M
Bottom line
Trupanion and Lemonade both posted fresh signs of momentum in pet insurance, though with very different business models. Trupanion reported first-quarter 2026 revenue of $384.0 million, up 12% year over year, with subscription revenue up 16% to $269.5 million and subscription enrolled pets up 5% to 1.1 million. The company also swung to net income of $4.9 million for the quarter. Lemonade, meanwhile, said its pet line surpassed $500 million in in-force premium early in the second quarter of 2026, making pet its largest line of business. In its Q1 2026 shareholder letter, Lemonade said pet had reached about $490 million in in-force premium at the end of the first quarter and described the category as its fastest-scaling product area. (sec.gov)
Why it matters: For veterinary professionals, these results point to a pet insurance market that’s still expanding, even as growth moderates from earlier breakneck years. NAPHIA said 7.03 million pets were insured in North America at the end of 2024, up 12.2% from 2023, while S&P Global reported U.S. pet insurance net premiums earned rose 11% in 2025 to a record $3.59 billion. Trupanion’s direct-to-veterinary-hospital payment model and Lemonade’s digital, direct-to-consumer approach represent two different paths to growth, but both could mean more insured visits, more financially feasible care plans, and more conversations with pet parents about coverage, claims, and affordability. (naphia.org)
What to watch: Watch whether Trupanion can reaccelerate pet enrollment while maintaining profitability, and whether Lemonade can keep scaling pet without sacrificing underwriting performance as it pushes beyond the $500 million mark. (sec.gov)
Two of the best-known names in pet insurance opened 2026 with new growth milestones, underscoring how competitive, and still underpenetrated, the category remains. Trupanion reported first-quarter revenue of $384.0 million, up 12% from a year earlier, while Lemonade said its pet business crossed $500 million in in-force premium early in the second quarter, becoming the company’s largest line of business. (sec.gov)
The backdrop is a U.S. pet insurance market that’s still growing at a double-digit pace, though not as fast as in prior years. NAPHIA’s 2025 State of the Industry report said 7.03 million pets were insured across North America at the end of 2024, including 6.4 million in the U.S. S&P Global Market Intelligence reported that U.S. pet insurance net premiums earned climbed 11% in 2025 to $3.59 billion, with Trupanion remaining the top underwriter and Lemonade posting one of the strongest premium growth rates among major players. (naphia.org)
For Trupanion, the quarter showed steady top-line growth and improving profitability. Alongside the 12% revenue gain, subscription business revenue rose 16% to $269.5 million, subscription enrolled pets increased 5% to 1,105,783, and the company reported net income of $4.9 million, compared with a net loss in the prior-year quarter. Trupanion said the widening gap between veterinary costs and what pet parents can plan for is helping support demand for coverage, and CEO Margi Tooth said the company is investing to broaden choice and strengthen its position with pet parents and veterinarians. (sec.gov)
Lemonade’s update was less about quarterly pet revenue than about scale. In its Q1 2026 shareholder letter, the company said pet surpassed $500 million in in-force premium early in the second quarter, after ending Q1 at roughly $490 million. Lemonade called pet its largest line of business and said the category became the first in its portfolio to reach that milestone. The company also said pet is now the No. 1 most-searched pet insurance brand in the U.S. and the fourth-largest carrier by written premium, while noting that about $85 million of pet in-force premium now comes from cross-sales to existing customers. (lemonade.com)
The contrast between the two companies is notable. Trupanion has long leaned on its veterinary-channel relationships and its direct-pay workflow, which lets participating hospitals receive payment at checkout rather than asking pet parents to pay first and wait for reimbursement. Lemonade has built pet as a digitally distributed product inside a broader insurance platform, using cross-sell and automation as growth levers. For clinics, that means the market is not consolidating around a single operating model. Instead, insurers are competing on convenience, channel strategy, brand reach, and claims experience. (sec.gov)
Why it matters: More insured pets can translate into greater acceptance of diagnostics, surgery, oncology, and other higher-cost recommendations, but the operational implications differ by insurer. Trupanion’s model may reduce front-desk friction when hospitals are connected to its payment system, while reimbursement-based models can still leave staff navigating cost estimates, claim questions, and payment timing with pet parents. At the same time, continued category growth is likely to keep pressure on practices to train teams on coverage basics, exclusions, pre-existing condition questions, and how different insurers handle payment. That matters in a market where penetration is still relatively low: Trupanion’s 2025 annual report, citing NAPHIA, said North American penetration for medical insurance for cats and dogs remains under 4%. (trupanion.com)
There are also signs that scale is arriving alongside more scrutiny on underwriting discipline and rate adequacy. Lemonade highlighted pet loss ratios that it said are comparable with peers despite taking less rate, while S&P Global reported the industry’s net loss ratio improved modestly in 2025 to 74.2% from 76.1% a year earlier. For veterinary teams, that’s worth watching because insurer growth, pricing actions, and claims performance all shape how sustainable coverage will feel to pet parents over time. (lemonade.com)
What to watch: The next phase is likely to center on execution rather than awareness: whether Trupanion can grow enrollments faster while staying profitable, whether Lemonade can convert scale into durable pet insurance economics, and whether both companies can keep expanding in a market that is still growing, but no longer growing effortlessly. (sec.gov)